<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND &amp; AIMS: Epidemiology studies have shown that <z:hpo ids='HP_0001513'>obesity</z:hpo> increases risk for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the contribution of <z:hpo ids='HP_0001513'>obesity</z:hpo>-induced increases in levels of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF)-α and <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> to the development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in mice </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Lean and <z:mp ids='MP_0001261'>obese</z:mp> mice (C57BL6/J and ob/ob) were given a combination of azoxymethane and <z:chebi fb="0" ids="34674">dextran sulfate</z:chebi> <z:chebi fb="199" ids="26708">sodium</z:chebi>, which led to the development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>; lean and <z:mp ids='MP_0001261'>obese</z:mp> severe combined immunodeficient mice were injected with HT-29 cells </plain></SENT>
<SENT sid="3" pm="."><plain>We analyzed the roles of TNF-α and insulin in the development of <z:hpo ids='HP_0001513'>obesity</z:hpo>-mediated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> using immunoblot, immunohistochemical, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> assays </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Genetic- and diet-induced <z:hpo ids='HP_0001513'>obesity</z:hpo> increased the incidence and size of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> that developed after administration of azoxymethane and <z:chebi fb="0" ids="34674">dextran sulfate</z:chebi> <z:chebi fb="199" ids="26708">sodium</z:chebi>, compared with lean mice </plain></SENT>
<SENT sid="5" pm="."><plain>HT-29 xenograft <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> grew more rapidly in <z:mp ids='MP_0001261'>obese</z:mp> than lean mice </plain></SENT>
<SENT sid="6" pm="."><plain>Neutralization of TNF-α reduced activation of c-Jun N-terminal kinase, IκB kinase, and the phosphatidylinositol 3-kinase-Akt-mammalian target of <z:chebi fb="0" ids="9168">rapamycin</z:chebi> signaling pathway; it also reduced the growth and development of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in <z:mp ids='MP_0001261'>obese</z:mp> mice </plain></SENT>
<SENT sid="7" pm="."><plain>Reducing levels of insulin levels had no effect on <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> in <z:mp ids='MP_0001261'>obese</z:mp> mice </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: TNF-α contributes to <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumor</z:e> growth in <z:mp ids='MP_0001261'>obese</z:mp> mice </plain></SENT>
<SENT sid="9" pm="."><plain>Reagents that inhibit TNF-α might prevent the development or progression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in <z:mp ids='MP_0001261'>obese</z:mp> individuals </plain></SENT>
</text></document>